CME Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - CME Group Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 210.94 USD -0.75%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast CME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CME is 230.99 USD with a low forecast of 186.85 USD and a high forecast of 262.5 USD.

CME Lowest Forecast

Wall Street Target

CME Average Forecast

Wall Street Target

CME Highest Forecast

Wall Street Target

11% Downside

10% Upside

24% Upside

The latest public price target was made on Apr 25, 2024 by Benjamin Budish from Barclays , who expects CME stock to rise by 8% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst	Price Target	Date	Article
Benjamin Budish Barclays	228 USD Upside 8%	4 days ago Apr 25, 2024	CME Group price target raised to $228 from $226 at Barclays TheFly
Andrew Bond Rosenblatt Securities	187 USD Downside 11%	4 days ago Apr 25, 2024	CME Group (CME) PT Raised to $187 at Rosenblatt StreetInsider
Brian Bedell Deutsche Bank	210 USD Downside 0%	3 weeks ago Apr 5, 2024	Deutsche Bank Downgrades CME Group (CME) to Hold StreetInsider
Unknown Analyst Credit Suisse	198 USD Downside 6%	1 year ago Feb 7, 2023	Credit Suisse Maintains Outperform on CME Group, Raises Price Target to $198 Benzinga

Price Target	228 USD
Upside/Downside	8%

Price Target	187 USD
Upside/Downside	11%

Price Target	210 USD
Upside/Downside	0%

Price Target	198 USD
Upside/Downside	6%

Intercontinental Exchange Inc

20% Upside

East Money Information Co Ltd

39% Upside

Coinbase Global Inc

1% Upside

S&P Global Inc

21% Upside

Intercontinental Exchange Inc

20% Upside

East Money Information Co Ltd

39% Upside

Coinbase Global Inc

1% Upside

S&P Global Inc

21% Upside

Hellenic Exchanges Athens Stock Exchange SA

19% Upside

Cboe Global Markets Inc

5% Upside

Saudi Tadawul Group Holding Company SJSC

23% Downside

Aquis Exchange PLC

86% Upside

Revenue
Forecast

For the last 8 years the compound annual growth rate for CME Group Inc's revenue is 16%. The projected CAGR for the next 3 years is -16%.

16%

-16%

2%

What are analyst estimates?

Operating Income
Forecast

For the last 8 years the compound annual growth rate for CME Group Inc's operating income is 20%. The projected CAGR for the next 3 years is -21%.

20%

-21%

-3%

What are analyst estimates?

Net Income
Forecast

For the last 8 years the compound annual growth rate for CME Group Inc's net income is 12%. The projected CAGR for the next 3 years is 6%.

12%

6%

-8%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for CME is 230.99 USD with a low forecast of 186.85 USD and a high forecast of 262.5 USD.

For the last 8 years the compound annual growth rate for CME Group Inc's revenue is 16%. The projected CAGR for the next 3 years is -16%.

For the last 8 years the compound annual growth rate for CME Group Inc's operating income is 20%. The projected CAGR for the next 3 years is -21%.

For the last 8 years the compound annual growth rate for CME Group Inc's net income is 12%. The projected CAGR for the next 3 years is 6%.

Join more than 132,400+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.